# Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects

> **NCT01079273** · PHASE4 · COMPLETED · sponsor: **Opera CRO, a TIGERMED Group Company** · enrollment: 7 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** egg-derived A/H1N1 pandemic influenza vaccine

## Key facts

- **NCT ID:** NCT01079273
- **Lead sponsor:** Opera CRO, a TIGERMED Group Company
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2012-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01079273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01079273, "Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01079273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*